TNF is a pro-inflammatory cytokine involved in various autoimmune diseases; TNF inhibitors include the immunomodulatory agents infliximab and adalimumab that bind to TNF-α to prevent it from interacting with its receptors (such as the TNF-α receptor), thereby reducing inflammation [47,48]. This evidence concerns the gene TNF and autoimmune disease.